Innovations in Medical Equipment: Molecular Targeting
One of the most important questions for cancer researchers has been “How do you develop a drug that targets cancer cells without destroying healthy cells?” This question has spawned the development of new medical equipment and pharmaceuticals that will revolutionize cancer treatment.
Thanks to recent developments in the field of molecular targeting, cancer specialists are able to design drugs that zero in on the molecular pathways of the disease itself without disrupting normal tissues and cells. Not only are these targeted drugs more effective than current medications, they are far less toxic to the body. By eliminating malignant tumors in such a targeted manner, patients are able to maintain a better quality of life without the adverse effects of chemotherapy treatment.
As pharmaceutical companies and the medical equipment industry strive to understand the circuitry of biological interactions at the molecular level, they are able to shut down one molecular pathway without disrupting another.
One company that has revolutionized this process is Polysciences, Inc. Their CellVue kits use proprietary technology to label targeted cells with fluorescent dye in the lipid, or plasma membranes of living cells. These dying kits are versatile enough to be used in on any cell type or bioparticle with minimal cell-to-cell transfer. Practitioners are able to put these kits to use with medical equipment like flow cytometers and highly specialized imaging medical equipment.
Like many other innovative medical techniques being used today, molecular targeting allows scientists and doctors to minimize the impact of many high-risk medical treatments and use information technology to change the way they look at disease.